The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.
June 06, 2019
This publication focuses on therapies (such as bisphosphonates) given to patient with myeloma bone lesions, lytic lesions, or myeloma bone disease.
May 18, 2019
This publication discusses how myeloma patients can manage vertebral compression fractures.
April 19, 2021
This publication discusses the use of Velcade (bortezomib)—a proteasome inhibitor—for the treatment of myeloma.
September 20, 2019
This booklet will introduce you to Xpovio™ (generic drug name selinexor)
July 03, 2018
This publication outlines the tests used to diagnose and monitor myeloma.
We Thank Our Sponsors:
Amgen, GSK, Janssen, Karyopharm Therapeutics, Oncopeptides, Inc. and Takeda